| 000 | 01657 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516132314.0 | ||
| 264 | 0 | _c20130930 | |
| 008 | 201309s 0 0 eng d | ||
| 022 | _a1931-3543 | ||
| 024 | 7 |
_a10.1378/chest.12-2357 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTse, Hoi Nam | |
| 245 | 0 | 0 |
_aHigh-dose N-acetylcysteine in stable COPD: the 1-year, double-blind, randomized, placebo-controlled HIACE study. _h[electronic resource] |
| 260 |
_bChest _cJul 2013 |
||
| 300 |
_a106-118 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAcetylcysteine _xadverse effects |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntioxidants _xadverse effects |
| 650 | 0 | 4 | _aAsian People |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 |
_aDyspnea _xepidemiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHong Kong |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPulmonary Disease, Chronic Obstructive _xdrug therapy |
| 650 | 0 | 4 | _aRespiratory Function Tests |
| 650 | 0 | 4 | _aSurveys and Questionnaires |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aWalking _xphysiology |
| 700 | 1 | _aRaiteri, Luca | |
| 700 | 1 | _aWong, King Ying | |
| 700 | 1 | _aYee, Kwok Sang | |
| 700 | 1 | _aNg, Lai Yun | |
| 700 | 1 | _aWai, Ka Yan | |
| 700 | 1 | _aLoo, Ching Kong | |
| 700 | 1 | _aChan, Ming Houng | |
| 773 | 0 |
_tChest _gvol. 144 _gno. 1 _gp. 106-118 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1378/chest.12-2357 _zAvailable from publisher's website |
| 999 |
_c22446358 _d22446358 |
||